UroGen Pharma
URGN
$13.22
Share price
0.08%
Change (1 day)
11.09%
Change (1 year)
Categories
Operating Margin for UroGen Pharma (URGN)
Operating Margin as of May 2024 (TTM): -167.85%
According to UroGen Pharma's latest financial reports and stock price the company's current Operating Margin is -167.85%. At the end of 2021 the company had an Operating Margin of -192.11%.
Operating Margin history for UroGen Pharma from 2017 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -192.11% | -82.12% |
| 2020 | -1,074.15% | -99.82% |
| 2019 | -608,211.11% | 8789.12% |
| 2018 | -6,842.20% | 2697.93% |
| 2017 | -244.55% | -5472.03% |
| 2016 | 4.55% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.